Barinthus Biotherapeutics plc (BRNS) — Strategic Asset Allocation Index
Barinthus Biotherapeutics plc (BRNS) has a Strategic Asset Allocation Index of 5.9% as of September 2022. Strategic assets (PP&E of $14.32 Million plus long-term investments of $-) total $14.32 Million, measured against net assets of $244.15 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Barinthus Biotherapeutics plc Strategic Asset Allocation Index (2021–2021)
This chart shows how Barinthus Biotherapeutics plc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of September 2022, the index stands at 5.9%, representing strategic assets of $14.32 Million against net assets of $244.15 Million USD. Explore cash flow conversion of Barinthus Biotherapeutics plc to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Barinthus Biotherapeutics plc (2021–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Barinthus Biotherapeutics plc from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Barinthus Biotherapeutics plc (BRNS) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.7% | $1.83 Million | $1.83 Million | $- | $252.56 Million | — |